PUBLISHER: IMARC | PRODUCT CODE: 1540845
PUBLISHER: IMARC | PRODUCT CODE: 1540845
Anticoagulants Market Report by Drug Class, Route of Administration, Distribution Channel, Application, and Region 2024-2032
The global anticoagulants market size reached US$ 41.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 90.9 Billion by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.
Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.
Anticoagulants Market Trends:
The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and application.
Drug Class Insights:
Novel Oral Anticoagulants (NOACs)
Heparin and Low Molecular Weight Heparin (LMWH)
Vitamin K Antagonist
Others
The report has provided a detailed breakup and analysis of the anticoagulants market based on the drug class. This includes novel oral anticoagulants (NOACs), heparin and low molecular weight heparin (LMWH), vitamin K antagonist, and others. According to the report, novel oral anticoagulants (NOACs) represented the largest segment.
Route of Administration Insights:
Oral Anticoagulant
Injectable Anticoagulant
A detailed breakup and analysis of the anticoagulants market based on the route of administration has also been provided in the report. This includes oral anticoagulant and injectable anticoagulant. According to the report, oral anticoagulant accounted for the largest market share.
Distribution Channel Insights:
Hospital Pharmacies
Retail Pharmacies
Online Stores
Others
A detailed breakup and analysis of the anticoagulants market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, hospital pharmacies accounted for the largest market share.
Application Insights:
Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
A detailed breakup and analysis of the anticoagulants market based on the application has also been provided in the report. This includes atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. According to the report, atrial fibrillation and heart attack accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1. What was the size of the global anticoagulants market in 2023?
- 2. What is the expected growth rate of the global anticoagulants market during 2024-2032?
- 3. What are the key factors driving the global anticoagulants market?
- 4. What has been the impact of COVID-19 on the global anticoagulants market?
- 5. What is the breakup of the global anticoagulants market based on the drug class?
- 6. What is the breakup of the global anticoagulants market based on the route of administration?
- 7. What is the breakup of the global anticoagulants market based on the distribution channel?
- 8. What is the breakup of the global anticoagulants market based on the application?
- 9. What are the key regions in the global anticoagulants market?
- 10. Who are the key players/companies in the global anticoagulants market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Anticoagulants Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Class
- 6.1 Novel Oral Anticoagulants (NOACs)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Heparin and Low Molecular Weight Heparin (LMWH)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Vitamin K Antagonist
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Route of Administration
- 7.1 Oral Anticoagulant
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Injectable Anticoagulant
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Application
- 9.1 Atrial Fibrillation and Heart Attack
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Stroke
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Deep Vein Thrombosis (DVT)
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Pulmonary Embolism (PE)
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Alexion Pharmaceuticals Inc
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Aspen Holdings
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Bayer AG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Boehringer Ingelheim International GmbH
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Bristol-Myers Squibb Company
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Daiichi Sankyo Company Limited
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Dr. Reddy's Laboratories Ltd
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 GlaxoSmithKline plc
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Johnson & Johnson Private Limited
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Sanofi
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Alexion Pharmaceuticals Inc
List of Figures
- Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
- Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2023
- Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2023
- Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2023
- Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2023
- Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2023
- Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 88: Global: Anticoagulants Industry: SWOT Analysis
- Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
- Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
- Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
- Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Anticoagulants Market: Competitive Structure
- Table 8: Global: Anticoagulants Market: Key Players
